262 related articles for article (PubMed ID: 19322916)
21. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
Yan F; Wang XM; Pan C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531
[TBL] [Abstract][Full Text] [Related]
22. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
Gu W; Fang FF; Li B; Cheng BB; Ling CQ
Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
[TBL] [Abstract][Full Text] [Related]
23. Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells.
Zheng W; Sai W; Yao M; Gu H; Yao Y; Qian Q; Yao D
Tumour Biol; 2015 May; 36(5):3995-4003. PubMed ID: 25600802
[TBL] [Abstract][Full Text] [Related]
24. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
[TBL] [Abstract][Full Text] [Related]
25. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111
[TBL] [Abstract][Full Text] [Related]
26. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU].
Tang HH; Zhou M; Liang G
Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785
[TBL] [Abstract][Full Text] [Related]
27. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
Yang JY; Luo HY; Lin QY; Liu ZM; Yan LN; Lin P; Zhang J; Lei S
World J Gastroenterol; 2002 Aug; 8(4):644-9. PubMed ID: 12174371
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
Jia L; Xu H; Zhao Y; Jiang L; Yu J; Zhang J
Cancer Invest; 2008 Dec; 26(10):977-83. PubMed ID: 19093255
[TBL] [Abstract][Full Text] [Related]
29. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
Dai DJ; Lu CD; Guo JM; Zhang J
Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
[TBL] [Abstract][Full Text] [Related]
30. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
[TBL] [Abstract][Full Text] [Related]
31. MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells.
Meng Q; He X; Xie G; Tian Q; Shu X; Li J; Xiao Y
Oncol Lett; 2017 Sep; 14(3):3089-3095. PubMed ID: 28928846
[TBL] [Abstract][Full Text] [Related]
32. [Down-regulated clusterin expression enhances sensitivity of hepatoma cells to anti-cancer drugs].
Zheng WJ; Sai WL; Yao M; Cai Y; Pan LH; Gu JJ; Wu W; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):844-8. PubMed ID: 26743245
[TBL] [Abstract][Full Text] [Related]
33. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
34. Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.
Chen G; Qiu H; Ke SD; Hu SM; Yu SY; Zou SQ
World J Gastroenterol; 2013 Apr; 19(16):2481-91. PubMed ID: 23674849
[TBL] [Abstract][Full Text] [Related]
35. [Intercellular transfer of P-glycoprotein in hepatocellular cell line HepG2].
Chen L; Zuo GQ; Wu JF; Zeng GL; Li T; Liu ZJ; Tang KF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):839-42. PubMed ID: 19958644
[TBL] [Abstract][Full Text] [Related]
36. Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma.
Mehdizadeh A; Somi MH; Darabi M; Jabbarpour-Bonyadi M
Mol Biol Rep; 2016 Feb; 43(2):107-16. PubMed ID: 26767647
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.
Liu ZH; Ma YL; He YP; Zhang P; Zhou YK; Qin H
Mol Biol Rep; 2011 Mar; 38(3):1769-75. PubMed ID: 20835928
[TBL] [Abstract][Full Text] [Related]
38. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
39. Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro.
Tian QE; De Li H; Yan M; Cai HL; Tan QY; Zhang WY
BMC Complement Altern Med; 2012 Jul; 12():94. PubMed ID: 22784390
[TBL] [Abstract][Full Text] [Related]
40. [Reversal of stemness in multidrug-resistant hepatocellular carcinoma cells by SIS3].
Yan W; Wen T; Lin S; Liu Z; Yang W; Wu G
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):731-5. PubMed ID: 26813590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
